Top compounds associated with response to CARD19


Feature Type Standardized
Nominal ANOVA
mRNA linifanib GDSC1000 pan-cancer AAC 0.12 0.001
mRNA UNC1215 GDSC1000 pan-cancer AAC -0.12 0.001
mRNA AZD6244 CCLE pan-cancer AAC 0.15 0.001
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA YM-155 CTRPv2 pan-cancer AAC -0.12 0.001
mRNA necrosulfonamide CTRPv2 pan-cancer AAC -0.13 0.001
mRNA Merck60 CTRPv2 pan-cancer AAC -0.099 0.001
mRNA Bexarotene GDSC1000 pan-cancer AAC 0.12 0.001
mRNA PD-0325901 gCSI pan-cancer AAC 0.17 0.001
mRNA PIK-93 GDSC1000 pan-cancer AAC -0.096 0.001
Download CSV